Li Nan (LN) has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $20.00M.
Profile
Li Nan (also rendered as Li Nan – Ln in some SEC filing contexts) is referenced in the 2026-05-12 SEC filings in connection with Odyssey Therapeutics, Inc. The available context identifies Li Nan as an insider or executive related to Odyssey Therapeutics, but the filings do not publicly confirm a specific title (e.g., CEO, CFO, director) as of the most recent filing date. Given the commonality of the name and the lack of additional corroborating information in the provided context, this biography focuses on the SEC context and acknowledges the need for verification of exact role and responsibilities. There is no independent confirmation from the provided data about other affiliations, career history, or notable achievements beyond association with Odyssey Therapeutics, Inc.
Role
Insider
Notability
15/100
Board memberships
Odyssey Therapeutics, Inc.
Awards & honors
Listed in Odyssey Therapeutics, Inc. SEC filings as an insider or executive (context dated 2026-05-12).
Li Nan (also rendered as Li Nan – Ln in some SEC filing contexts) is referenced in the 2026-05-12 SEC filings in connection with Odyssey Therapeutics, Inc. The available context identifies Li Nan as an insider or executive related to Odyssey Therapeutics, but the filings do not publicly confirm a specific title (e.g., CEO, CFO, director) as of the most recent filing date. Given…
How many SEC Form 4 filings has Li Nan (LN) submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Li Nan (LN) been buying or selling stock?
Recorded transactions: 1 open-market purchases ($20.00M) and 0 open-market sales () across all tracked filings.
Where can I see all of Li Nan (LN)'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
